FDA Inspection 1071020 — Dendreon Corporation

Dendreon Corporation — FEI 3000204836

The FDA completed an inspection of Dendreon Corporation on Nov 2, 2018 in Seattle, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 2, 2018
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Seattle, WA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.